OutSee, an AI-enabled genomics and drug discovery company, has closed a £2.5 million seed funding round and signed a strategic agreement with o2h discovery to begin a collaborative drug discovery ...
Oxygen Healthcare Ltd. (O2h),a Piramal Group Companyand ChromocellCorporation, an emerging life sciences company active in both flavors and therapeutics discovery, today signed an agreement under ...
Executives from O2h (Cambridge, UK) and Heptares Therapeutics (Welwyn Garden City, UK) signed an agreement to substantially increase the number of FTE chemists provided by O2h to support discovery ...
CAMBRIDGE, England--(BUSINESS WIRE)--OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its ...
CAMBRIDGE, England--(BUSINESS WIRE)--PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a collaboration with o2h ...
Ahmedabad (Gujarat) [India], March 6: The 7th o2h Collaborative Innovation Conference successfully concluded at Hyatt Regency Ahmedabad, bringing together a distinguished lineup of experts from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results